Opus GeneticsIRD
13F holders, Q3 2025 (September 30)At the end of Q3 2025, 48 institutions reported holding Opus Genetics Inc. (IRD) in their 13F filings, up 5 from Q2 2025. 10 opened new positions and 4 sold out. The largest holders were Perceptive Advisors LLC ($7.1M), BIOS Capital Management, LP ($6.6M) and Nantahala Capital Management, LLC ($5.5M). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Opus Genetics Inc.
- CUSIP
- 67577R102
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 10 | $2.1M |
| Exits | 4 | $203K |
All 13F filers, Q2 2025 → Q3 2025: 2,039,992 shares bought and 490,334 shares sold, net +1,549,658 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 48 holders
| Perceptive Advisors LLC | 0.21% | No change | 4,325,000 | $7.1M |
| BIOS Capital Management, LP | 7.42% | No change | 3,683,429 | $6.6M |
| Nantahala Capital Management, LLC | 0.34% | No change | 3,345,923 | $5.5M |
| Vanguard Group Inc. | 0.00% | Add +35.3% | 1,342,025 | $2.2M |
| Mink Brook Asset Management LLC | 1.38% | Add +3.4% | 1,237,947 | $2.0M |
| Opaleye Management Inc. | 0.26% | Reduce -9.8% | 1,100,000 | $1.8M |
| Adage Capital Partners Gp, L.L.C. | 0.00% | New | 954,996 | $1.6M |
| Bleichroeder LP | 0.24% | No change | 736,842 | $1.2M |
| Voss Capital, LP | 0.05% | Add +3.9% | 562,377 | $928K |
| Geode Capital Management, LLC | 0.00% | Add +31.8% | 468,937 | $774K |
| Renaissance Technologies | 0.00% | Add +13.4% | 173,809 | $287K |
| State Street Corp. | 0.00% | Add +107.0% | 145,873 | $241K |
| Creative Planning | 0.00% | New | 128,366 | $212K |
| Citadel Advisors | 0.00% | New | 113,416 | $187K |
| Two Sigma Investments, LP | 0.00% | Add +169.6% | 108,338 | $179K |
| Northern Trust Corp. | 0.00% | No change | 68,228 | $113K |
| XTX Topco Ltd | 0.00% | Add +227.4% | 51,757 | $85K |
| BlackRock, Inc. | 0.00% | No change | 46,094 | $76K |
| Bridgeway Capital Management, LLC | 0.00% | No change | 42,065 | $69K |
| Empowered Funds, LLC | 0.00% | No change | 42,065 | $69K |
| Simplex Trading, LLC | 0.00% | New | 32,847 | $54K |
| Captrust Financial Advisors | 0.00% | No change | 32,000 | $53K |
| Morgan Stanley | 0.00% | No change | 28,606 | $47K |
| Blair William & Co. | 0.00% | No change | 24,466 | $40K |
| Raymond James Financial Inc. | 0.00% | Add +95.6% | 22,508 | $37K |
| HRT Financial LP | 0.00% | New | 20,677 | $34K |
| Susquehanna International Group, LLP | 0.00% | Add +16.8% | 20,213 | $33K |
| Kestra Private Wealth Services, LLC | 0.00% | No change | 19,000 | $31K |
| Two Sigma Securities, LLC | 0.00% | New | 17,746 | $29K |
| James Investment Research, Inc. | 0.00% | No change | 16,364 | $27K |
| NewEdge Advisors, LLC | 0.00% | No change | 16,364 | $27K |
| Bedel Financial Consulting, Inc. | 0.00% | No change | 15,000 | $25K |
| Osaic Holdings, Inc. | 0.00% | Add +0.0% | 13,904 | $24K |
| Prudential Financial Inc. | 0.00% | New | 13,100 | $22K |
| Stokes Family Office, LLC | 0.00% | No change | 12,120 | $20K |
| Comerica Bank | 0.00% | No change | 12,000 | $20K |
| Reliant Investment Partners, LLC | 0.01% | No change | 10,000 | $19K |
| Two Sigma Advisers, LP | 0.00% | New | 10,200 | $17K |
| Annandale Capital, LLC | 0.00% | New | 10,000 | $17K |
| Wells Fargo & Company | 0.00% | No change | 3,785 | $6K |
| SBI Securities Co., Ltd. | 0.00% | Reduce -27.9% | 2,582 | $4K |
| National Bank of Canada | 0.00% | No change | 2,014 | $3K |
| Barclays PLC | 0.00% | No change | 1,900 | $3K |
| UBS Group AG | 0.00% | Reduce -96.9% | 884 | $1K |
| Bank of America Corp. | 0.00% | Add +34.4% | 383 | $632 |
| MAI Capital Management | 0.00% | No change | 123 | $203 |
| Citigroup Inc. | 0.00% | New | 1 | $2 |
| Royal Bank of Canada | 0.00% | Reduce -100.0% | 30 | $0 |
"% of holder's portfolio" is IRD's weight in each manager's 13F, not the share of Opus Genetics Inc. the manager owns.